GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » Other Gross PPE

SynBiotic SE (XTER:SBX) Other Gross PPE : €6.06 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE Other Gross PPE?

SynBiotic SE's Other Gross PPE for the quarter that ended in Dec. 2023 was €6.06 Mil.

SynBiotic SE's quarterly Other Gross PPE increased from Jun. 2022 (€0.00 Mil) to Dec. 2022 (€6.10 Mil) but then declined from Dec. 2022 (€6.10 Mil) to Dec. 2023 (€6.06 Mil).

SynBiotic SE's annual Other Gross PPE increased from Dec. 2021 (€5.93 Mil) to Dec. 2022 (€6.10 Mil) but then declined from Dec. 2022 (€6.10 Mil) to Dec. 2023 (€6.06 Mil).


SynBiotic SE Other Gross PPE Historical Data

The historical data trend for SynBiotic SE's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE Other Gross PPE Chart

SynBiotic SE Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial - 0.03 5.93 6.10 6.06

SynBiotic SE Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Dec23
Other Gross PPE Get a 7-Day Free Trial Premium Member Only - 5.93 - 6.10 6.06

SynBiotic SE Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


SynBiotic SE Business Description

Traded in Other Exchanges
Address
Barer Strasse 7, Munich, BY, DEU, 80333
SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.
Executives
Daniel Kruse Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines